应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BEAM Beam Therapeutics, Inc.
盘前交易 02-18 07:42:01 EST
27.49
-0.43
-1.54%
盘前
27.40
-0.09
-0.33%
06:09 EST
最高
28.08
最低
26.20
成交量
124.00万
今开
27.56
昨收
27.92
日振幅
6.73%
总市值
27.90亿
流通市值
24.73亿
总股本
1.01亿
成交额
3,403万
换手率
1.38%
流通股本
8,994万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
基因药物开发取得进展 Beam Therapeutics (BEAM.US)股价大涨
智通财经 · 01-13
基因药物开发取得进展 Beam Therapeutics (BEAM.US)股价大涨
Coinbase 将于 12月 16 日 上线 Beam (BEAM) 现货交易
链捕手 · 2025-12-16
Coinbase 将于 12月 16 日 上线 Beam (BEAM) 现货交易
Coinbase将上线Beam (BEAM)
Blockbeats · 2025-12-15
Coinbase将上线Beam (BEAM)
Beam Therapeutics 更新 Ristoglogene Autogetemcel (Risto-Cel) 的 Beacon 1/2 期临床试验数据,展现镰状细胞病的持久、差异化疗效
美股速递 · 2025-12-06
Beam Therapeutics 更新 Ristoglogene Autogetemcel (Risto-Cel) 的 Beacon 1/2 期临床试验数据,展现镰状细胞病的持久、差异化疗效
Coinbase 将 Beam(BEAM) 列入上币路线图
链捕手 · 2025-12-04
Coinbase 将 Beam(BEAM) 列入上币路线图
Beam Therapeutics Inc.盘中异动 早盘股价大涨5.05%
市场透视 · 2025-10-08
Beam Therapeutics Inc.盘中异动 早盘股价大涨5.05%
Beam Therapeutics Inc.盘中异动 大幅下跌5.20%报27.00美元
市场透视 · 2025-03-10
Beam Therapeutics Inc.盘中异动 大幅下跌5.20%报27.00美元
Beam Therapeutics Inc.盘中异动 股价大跌5.09%
市场透视 · 2025-03-06
Beam Therapeutics Inc.盘中异动 股价大跌5.09%
Beam Therapeutics Inc.盘中异动 早盘急速下挫5.18%报23.80美元
市场透视 · 2025-03-04
Beam Therapeutics Inc.盘中异动 早盘急速下挫5.18%报23.80美元
数据:在PEPE、BEAM等代币上损失千万美元的巨鲸转向购买BTC和MKR
金色财经 · 2025-03-04
数据:在PEPE、BEAM等代币上损失千万美元的巨鲸转向购买BTC和MKR
Beam Therapeutics Inc.盘中异动 下午盘股价大跌5.13%报24.99美元
市场透视 · 2025-03-04
Beam Therapeutics Inc.盘中异动 下午盘股价大跌5.13%报24.99美元
某巨鲸以1.17美元均价增持534万枚ONDO,曾投资PEPE及BEAM亏损超1400万美元
金色财经 · 2025-03-03
某巨鲸以1.17美元均价增持534万枚ONDO,曾投资PEPE及BEAM亏损超1400万美元
Beam Therapeutics Inc.2024财年实现净利润-3.77亿美元,同比减少183.46%
市场透视 · 2025-03-01
Beam Therapeutics Inc.2024财年实现净利润-3.77亿美元,同比减少183.46%
Beam Therapeutics Inc.盘中异动 大幅下跌5.06%报28.33美元
市场透视 · 2025-02-27
Beam Therapeutics Inc.盘中异动 大幅下跌5.06%报28.33美元
Beam Therapeutics 2024年第四季度GAAP每股收益$(1.09)好于预期$(1.18),截至第四季度末持有8.507亿美元现金及有价证券,预计运营资金可支撑至2027年
财报速递 · 2025-02-25
Beam Therapeutics 2024年第四季度GAAP每股收益$(1.09)好于预期$(1.18),截至第四季度末持有8.507亿美元现金及有价证券,预计运营资金可支撑至2027年
Beam Therapeutics Inc.盘中异动 股价大跌5.07%
市场透视 · 2025-02-22
Beam Therapeutics Inc.盘中异动 股价大跌5.07%
Beam Therapeutics Inc.盘中异动 早盘大幅上涨5.03%报34.03美元
市场透视 · 2025-02-18
Beam Therapeutics Inc.盘中异动 早盘大幅上涨5.03%报34.03美元
Beam Therapeutics Inc.盘中异动 急速上涨5.10%
市场透视 · 2025-02-14
Beam Therapeutics Inc.盘中异动 急速上涨5.10%
AI医疗股美股盘前大涨,Recursion涨12%,木头姐押注AI医药革命
老虎资讯综合 · 2025-02-06
AI医疗股美股盘前大涨,Recursion涨12%,木头姐押注AI医药革命
加载更多
公司概况
公司名称:
Beam Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Beam Therapeutics Inc.成立于2017年1月25日,是一家生物技术公司,致力于根据其专有的碱基编辑技术创建一类新型的精密基因药物,其愿景是为患有严重疾病的患者提供终身治疗疾病。
发行价格:
--
{"stockData":{"symbol":"BEAM","market":"US","secType":"STK","nameCN":"Beam Therapeutics, Inc.","latestPrice":27.49,"timestamp":1771362000000,"preClose":27.92,"halted":0,"volume":1239971,"hourTrading":{"tag":"盘前","latestPrice":27.4,"preClose":27.49,"latestTime":"06:09 EST","volume":14,"amount":384.199984,"timestamp":1771412964730,"change":-0.09,"changeRate":-0.003274,"amplitude":0.005457},"delay":0,"changeRate":-0.015401146131805274,"floatShares":89942800,"shares":101474944,"eps":-4.419301,"marketStatus":"盘前交易","change":-0.43,"latestTime":"02-18 07:42:01 EST","open":27.56,"high":28.08,"low":26.2,"amount":34026639.39708,"amplitude":0.067335,"askPrice":28.9,"askSize":13,"bidPrice":27.09,"bidSize":218,"shortable":3,"etf":0,"ttmEps":-4.419301,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771425000000},"marketStatusCode":1,"adr":0,"listingDate":1580965200000,"exchange":"NASDAQ","adjPreClose":27.49,"preHourTrading":{"tag":"盘前","latestPrice":27.4,"preClose":27.49,"latestTime":"06:09 EST","volume":14,"amount":384.199984,"timestamp":1771412964730,"change":-0.09,"changeRate":-0.003274,"amplitude":0.005457},"postHourTrading":{"tag":"盘后","latestPrice":27.5,"preClose":27.49,"latestTime":"19:34 EST","volume":28324,"amount":779663.09,"timestamp":1771374898787,"change":0.01,"changeRate":0.000364,"amplitude":0.036741},"volumeRatio":0.7804773471973485,"impliedVol":1.045,"impliedVolPercentile":0.96},"requestUrl":"/m/hq/s/BEAM","defaultTab":"news","newsList":[{"id":"2603575413","title":"基因药物开发取得进展 Beam Therapeutics (BEAM.US)股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575413","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603575413?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:16","pubTimestamp":1768270560,"startTime":"0","endTime":"0","summary":"智通财经APP注意到,Beam Therapeutics 股价在周一大幅上涨超20%,截至收盘,该股涨22.29%,报33.69美元,此前该公司发布了关于持续致力于建立可持续、可预测模式以推进精准基因药物开发的最新进展。截至 2025 年底,公司持有的现金、现金等价物及有价证券估值约为 12.5 亿美元;预计运营资金支持期限将延长至 2029 年,这将为 risto-cel 的预期上市以及 BEAM-302 关键开发计划的执行提供有力支持。此外,该公司肝脏靶向基因疾病特许经营项目的扩张正在进行中,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4505","BK4139","BK4611","BK4539","BK4556","BK4585","BEAM","LENZ","BK4535","BK4007"],"gpt_icon":0},{"id":"2591022676","title":"Coinbase 将于 12月 16 日 上线 Beam (BEAM) 现货交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2591022676","media":"链捕手","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591022676?lang=zh_cn&edition=full","pubTime":"2025-12-16 09:22","pubTimestamp":1765848170,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,Coinbase Markets 宣布将于 2025 年 12 月 16 日上线 Beam (BEAM) 现货交易,BEAM-USD 交易对将在当日太平洋时间 9:00 之后、流动性条件满足的情况下开放,适用于支持交易的地区。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2229897","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","BK4600","BK4505","BK4139","BK4596","BK4535","BK4516","LU2360107671.USD","BK4595","LU1861559042.SGD","BK4588","BK4554","BK4539","BK4551","LU1861220207.SGD","LU1861558580.USD","BK4585","BK4611","LU1861217088.USD","BK4556","BK4112"],"gpt_icon":0},{"id":"2591623184","title":"Coinbase将上线Beam (BEAM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2591623184","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591623184?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:55","pubTimestamp":1765788900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/324498","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["LU1861558580.USD","BK4535","BK4139","BK4505","BK4554","BK4595","LU1861559042.SGD","BK4539","BEAM","COIN","BK4585","BK4600","BK4611","CONL","LU1861217088.USD","BK4551","LU1861220207.SGD","BK4112","LU2360107671.USD","BK4588","BK4516","BK4596","BK4556"],"gpt_icon":0},{"id":"1196920972","title":"Beam Therapeutics 更新 Ristoglogene Autogetemcel (Risto-Cel) 的 Beacon 1/2 期临床试验数据,展现镰状细胞病的持久、差异化疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1196920972","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196920972?lang=zh_cn&edition=full","pubTime":"2025-12-06 21:01","pubTimestamp":1765026085,"startTime":"0","endTime":"0","summary":"Beam Therapeutics 更新了 Ristoglogene Autogetemcel (Risto-Cel) 在美国血液学会 (ASH) 年会上关于 Beacon 1/2 期临床试验的数据,强调了其在镰状细胞病 (SCD) 中的持久和差异化疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4611","BK4556","BK4585","BEAM","BK4535","BK4588"],"gpt_icon":0},{"id":"2588732020","title":"Coinbase 将 Beam(BEAM) 列入上币路线图","url":"https://stock-news.laohu8.com/highlight/detail?id=2588732020","media":"链捕手","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588732020?lang=zh_cn&edition=full","pubTime":"2025-12-04 08:17","pubTimestamp":1764807425,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息,据官方公告,Coinbase 已将 Beam(BEAM)纳入其上币路线图,后续将视技术与合规审核进展决定具体上线时间。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2226119","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","BK4596","BK4611","LU1861220207.SGD","BK4554","LU1861558580.USD","BK4539","BK4516","BK4588","BK4505","BK4556","BK4535","COIN","BK4112","BK4585","LU2360107671.USD","BK4551","LU1861559042.SGD","BK4600","BK4139","LU1861217088.USD","BK4595"],"gpt_icon":0},{"id":"2574383184","title":"Beam Therapeutics Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574383184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574383184?lang=zh_cn&edition=full","pubTime":"2025-10-08 22:35","pubTimestamp":1759934140,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日22时35分,Beam Therapeutics Inc.股票出现异动,股价快速上涨5.05%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家生物技术公司,致力于基于其专有的碱基编辑技术开发一类新的精准基因药物,为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008223540a4573cd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008223540a4573cd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4611","BK4539","BK4556","BEAM","BK4585","BK4535","BK4505","BK4007","LENZ","BK4588"],"gpt_icon":0},{"id":"2518220291","title":"Beam Therapeutics Inc.盘中异动 大幅下跌5.20%报27.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220291?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:03","pubTimestamp":1741615383,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时03分,Beam Therapeutics Inc.股票出现异动,股价急速下跌5.20%。截至发稿,该股报27.00美元/股,成交量237.165万股,换手率2.83%,振幅3.72%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.08%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4585","BEAM","BK4139","BK4588","BK4556","BK4505","LENZ","BK4611"],"gpt_icon":0},{"id":"2517200169","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517200169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517200169?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271528,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分,Beam Therapeutics Inc.股票出现异动,股价大幅下挫5.09%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.66%。其相关个股中,Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大,Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为953.51%、104.36%、48.88%,振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.,振幅分别为24.20%、13.05%、11.88%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BEAM","BK4585","BK4556","BK4588","BK4535","BK4139"],"gpt_icon":0},{"id":"2516670089","title":"Beam Therapeutics Inc.盘中异动 早盘急速下挫5.18%报23.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670089?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:52","pubTimestamp":1741099972,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时52分,Beam Therapeutics Inc.股票出现异动,股价大幅跳水5.18%。截至发稿,该股报23.80美元/股,成交量20.2093万股,换手率0.24%,振幅2.47%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.32%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","BK4505","BK4585","BK4588","BK4535","BK4139","BK4556","LENZ"],"gpt_icon":0},{"id":"2516619511","title":"数据:在PEPE、BEAM等代币上损失千万美元的巨鲸转向购买BTC和MKR","url":"https://stock-news.laohu8.com/highlight/detail?id=2516619511","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516619511?lang=zh_cn&edition=full","pubTime":"2025-03-04 12:42","pubTimestamp":1741063374,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896779398776512797","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4601","MKR.USD.HKCC","BTC.USD.HKCC","XBTmain","MKR.USD.CC","BK4505","BK4585","BK4535","BTCmain","BK4556","BTC","BEAM","BK4139","ETH.USD.HKCC","ETH","BK4588"],"gpt_icon":0},{"id":"2516663938","title":"Beam Therapeutics Inc.盘中异动 下午盘股价大跌5.13%报24.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663938?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:28","pubTimestamp":1741033681,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时28分,Beam Therapeutics Inc.股票出现波动,股价大幅跳水5.13%。截至发稿,该股报24.99美元/股,成交量81.582万股,换手率0.97%,振幅6.47%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BEAM","BK4588","BK4535","BK4505","BK4556","LENZ","BK4139"],"gpt_icon":0},{"id":"2516786035","title":"某巨鲸以1.17美元均价增持534万枚ONDO,曾投资PEPE及BEAM亏损超1400万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516786035","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516786035?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:58","pubTimestamp":1740970730,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896388254917955585","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4505","BK4535","BEAM","BK4585","BK4588","BK4139","MKR.USD.HKCC","BK4556"],"gpt_icon":0},{"id":"2516341379","title":"Beam Therapeutics Inc.2024财年实现净利润-3.77亿美元,同比减少183.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516341379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516341379?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:01","pubTimestamp":1740758461,"startTime":"0","endTime":"0","summary":"3月1日,Beam Therapeutics Inc.公布财报,公告显示公司2024财年净利润为-3.77亿美元,同比减少183.46%;其中营业收入为63.52百万美元,同比减少83.20%,每股基本收益为-4.58美元。从资产负债表来看,Beam Therapeutics Inc.总负债3.70亿美元,其中短期债务13.47百万美元,资产负债比为2.99,流动比率为4.83。机构评级:截至2025年3月1日,当前有14家机构对Beam Therapeutics Inc.目标价做出预测,其中目标均价为48.43美元,其中最低目标价为24.00美元,最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000154a258185b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000154a258185b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","LENZ"],"gpt_icon":0},{"id":"2514186503","title":"Beam Therapeutics Inc.盘中异动 大幅下跌5.06%报28.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514186503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514186503?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:57","pubTimestamp":1740592630,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时57分,Beam Therapeutics Inc.股票出现异动,股价急速下挫5.06%。截至发稿,该股报28.33美元/股,成交量52.8583万股,换手率0.63%,振幅5.50%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.43%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270157109893d107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270157109893d107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","BK4505","LENZ","BK4556","BK4588","BK4585","BK4139","BK4535"],"gpt_icon":0},{"id":"1166657736","title":"Beam Therapeutics 2024年第四季度GAAP每股收益$(1.09)好于预期$(1.18),截至第四季度末持有8.507亿美元现金及有价证券,预计运营资金可支撑至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1166657736","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166657736?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:39","pubTimestamp":1740487180,"startTime":"0","endTime":"0","summary":"Beam Therapeutics报告季度每股亏损$,好于分析师预期的$,超出预期7.63%。相比去年同期盈余的$1.73,这一数字下降了163.01%。以上内容来自Benzinga Earnings专栏,原文如下:Beam $Therapeutics$ reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 7.63 percent. This is a 163.01 percent decrease over earnings of $1.73 per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BEAM"],"gpt_icon":0},{"id":"2513899211","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513899211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513899211?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:07","pubTimestamp":1740164828,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时07分,Beam Therapeutics Inc.股票出现异动,股价快速下跌5.07%。截至发稿,该股报31.46美元/股,成交量84.827万股,换手率1.02%,振幅7.39%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.34%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030709abd7e75f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030709abd7e75f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4588","BK4505","BK4585","BEAM","BK4556","BK4535"],"gpt_icon":0},{"id":"2512165058","title":"Beam Therapeutics Inc.盘中异动 早盘大幅上涨5.03%报34.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165058?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889142,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分,Beam Therapeutics Inc.股票出现波动,股价大幅拉升5.03%。截至发稿,该股报34.03美元/股,成交量5.7035万股,换手率0.07%,振幅1.33%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.11%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232229889fcc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232229889fcc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4535","BK4585","BK4505","BK4139","BK4588","BEAM","LENZ"],"gpt_icon":0},{"id":"2511913026","title":"Beam Therapeutics Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511913026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511913026?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:35","pubTimestamp":1739543713,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时35分,Beam Therapeutics Inc.股票出现异动,股价大幅上涨5.10%。Beam Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大,Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为1116.01%、376.90%、348.40%,振幅较大的相关个股有Moleculin Biotech, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.,振幅分别为23.62%、20.20%、19.73%。Beam Therapeutics Inc.公司简介:Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223513a24601f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223513a24601f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4585","BEAM","BK4139","BK4588","BK4556","BK4505","LENZ"],"gpt_icon":0},{"id":"1190923946","title":"AI医疗股美股盘前大涨,Recursion涨12%,木头姐押注AI医药革命","url":"https://stock-news.laohu8.com/highlight/detail?id=1190923946","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190923946?lang=zh_cn&edition=full","pubTime":"2025-02-06 18:38","pubTimestamp":1738838298,"startTime":"0","endTime":"0","summary":"AI医疗股美股盘前大涨, $Recursion Pharmaceuticals, Inc.$涨12%, $CRISPR Therapeutics AG$涨近3%, $Tempus AI$ 涨超3%, $Beam Therapeutics, Inc.$涨7%。其中,在多组学测序方面,报告指出,在海量多组学数据的支持下,结合可编程生物学的驱动,运行自主实验室的AI系统可能会显著降低药物研发全流程的成本,从而改变这个长期停滞的制药行业的回报状况。当前,木头姐的Ark Invest的投资组合中的AI医药股包括RXRX、CRSP、TEM、TWST和BEAM等前景看好的医疗保健股票。","market":"us","thumbnail":"https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c5f6cd84096ca9b3b893fb788b76d134"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e7bade5441f3188afd7433cdebf8e440","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"AI医疗股大涨,木头姐押注AI医药革命","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","CRSP","BEAM","TEM"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.beamtx.com","stockEarnings":[{"period":"1week","weight":0.02},{"period":"1month","weight":-0.1195},{"period":"3month","weight":0.3103},{"period":"6month","weight":0.7171},{"period":"1year","weight":-0.1515},{"period":"ytd","weight":-0.0083}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0127},{"period":"3month","weight":0.0305},{"period":"6month","weight":0.0744},{"period":"1year","weight":0.12},{"period":"ytd","weight":0.0014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beam Therapeutics Inc.成立于2017年1月25日,是一家生物技术公司,致力于根据其专有的碱基编辑技术创建一类新型的精密基因药物,其愿景是为患有严重疾病的患者提供终身治疗疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.016429},{"month":2,"riseRate":0.5,"avgChangeRate":0.10207},{"month":3,"riseRate":0,"avgChangeRate":-0.205206},{"month":4,"riseRate":0.5,"avgChangeRate":-0.128126},{"month":5,"riseRate":0.5,"avgChangeRate":0.074807},{"month":6,"riseRate":0.833333,"avgChangeRate":0.150103},{"month":7,"riseRate":0.5,"avgChangeRate":0.084734},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.03415},{"month":9,"riseRate":0.333333,"avgChangeRate":0.012795},{"month":10,"riseRate":0.5,"avgChangeRate":0.022792},{"month":11,"riseRate":0.833333,"avgChangeRate":0.165588},{"month":12,"riseRate":0.5,"avgChangeRate":0.076029}],"exchange":"NASDAQ","name":"Beam Therapeutics, Inc.","nameEN":"Beam Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beam Therapeutics, Inc.,BEAM,Beam Therapeutics, Inc.股票,Beam Therapeutics, Inc.股票老虎,Beam Therapeutics, Inc.股票老虎国际,Beam Therapeutics, Inc.行情,Beam Therapeutics, Inc.股票行情,Beam Therapeutics, Inc.股价,Beam Therapeutics, Inc.股市,Beam Therapeutics, Inc.股票价格,Beam Therapeutics, Inc.股票交易,Beam Therapeutics, Inc.股票购买,Beam Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}